Biologics in patients with skin diseases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28477721.
- Also identified by DOI 10.1016/j.jaci.2017.03.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biologic agents are important therapeutic options for treating multiple moderate-to-severe cutaneous diseases. Monoclonal antibodies already in use or under investigation are targeted for psoriasis, atopic dermatitis, melanoma, hidradenitis suppurativa, and pemphigus vulgaris.
Medical subject headings
- Antibodies, Monoclonal
- Biological Products
- Skin Diseases